Literature DB >> 8779896

Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy.

M Roberts1, M D Lindheimer, J M Davison.   

Abstract

Hyperfiltration precedes renal function loss in several nephropathies. Animal studies suggest this may be due to accompanying increases in transglomerular capillary hydrostatic pressure difference (delta P) and/or altered glomerular processing of macromolecules. Renal hemodynamics increase strikingly in human pregnancy. To test the hypothesis that these alterations are not potentially harmful, clearances of inulin, p-aminohippurate, and neutral dextrans were measured at 16- and 36-wk gestation, then 4 mo postpartum, in 11 normotensive women. Results were analyzed using two computer modeling programs. Glomerular filtration rate and renal plasma flow (RPF) were markedly elevated in early and late pregnancy (135 +/- 6 and 895 +/- 53 and 135 +/- 6 and 754 +/- 32 ml/min, respectively, vs. 87 +/- 7 and 520 +/- 17 ml/min postpartum). Gestational hyperfiltration was primarily due to RPF increments with a minor contribution from decrements in capillary oncotic pressure. Fractional dextran clearances (particularly the smaller dextrans, 30-39 A radii) were lower in early pregnancy, decreasing further in late pregnancy. There was no evidence of increased delta P and alterations in glomerular membrane porosity resolved postpartum. These data provide a database by which to study effects of pregnancy on chronic renal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779896     DOI: 10.1152/ajprenal.1996.270.2.F338

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

Review 1.  Impact of pregnancy on underlying renal disease.

Authors:  Chris Baylis
Journal:  Adv Ren Replace Ther       Date:  2003-01

Review 2.  Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

Authors:  André Dallmann; Ibrahim Ince; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

3.  Spot urine protein measurements in normotensive pregnancies, pregnancies with isolated proteinuria and preeclampsia.

Authors:  Andrea Kattah; Natasa Milic; Wendy White; Vesna Garovic
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-26       Impact factor: 3.619

Review 4.  Maternal vasodilation in pregnancy: the emerging role of relaxin.

Authors:  Kirk P Conrad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

Review 5.  Pathophysiology of pre-eclampsia: update on the role of nitric oxide.

Authors:  Maki Kashiwagi; Roland Zimmermann; Ernst Beinder
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

6.  Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Authors:  Aida Kulo; Mariska Y Peeters; Karel Allegaert; Anne Smits; Jan de Hoon; Rene Verbesselt; Liesbeth Lewi; Marc van de Velde; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Examination of Prepregnancy and Pregnancy Urinary Protein Levels in Healthy Nulliparous Women.

Authors:  Julie K Phillips; Carole A McBride; Sarah A Hale; Richard J Solomon; Gary J Badger; Ira M Bernstein
Journal:  Reprod Sci       Date:  2016-07-28       Impact factor: 3.060

Review 8.  Renal physiology of pregnancy.

Authors:  Katharine L Cheung; Richard A Lafayette
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

9.  Renal function in normal and disordered pregnancy.

Authors:  Wael Hussein; Richard A Lafayette
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-01       Impact factor: 2.894

Review 10.  The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Authors:  Kirk P Conrad; John M Davison
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.